Anthracyclines, such as doxorubicin, and monoclonal antibodies, such as trastuzumab, are compounds of wide clinical use as cytotoxic chemotherapy as they. Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial Neutropenia inducida por dosis terapéuticas de metronidazol intravenoso. cardiotoxicidad inducida por quimioterapia, además de hacer una síntesis de los diferentes . tion (anthracyclines, trastuzumab, tyrosine kinase inhibitors.
|Published (Last):||9 December 2007|
|PDF File Size:||2.57 Mb|
|ePub File Size:||2.62 Mb|
|Price:||Free* [*Free Regsitration Required]|
There was a problem providing the content you requested
Based on data found in the research, a need to combine efforts among efforts among oncologists, cardiologists, nurses and clinical pharmacists was recognized, in order to identify these adverse events.
Review role of topotecan in gynaecological cancers: Cardiotoxicity of anticancer drugs: Prasugrel as trastuumab potential cancer promoter: Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3. Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?
Reversibility of left ventricular dysfunction resulting from chemotherapy: Int J Hyg Environ Health. Left ventricular ejection fraction and cardiotoxicity: Current and emerging treatment strategies for cutaneous T-cell lymphoma.
Therefore, these drugs produce undesirable side effects and are toxic to those taking such medications 1.
Guidelines for cardiac monitoring of children during and after anthracycline therapy: J Sci Med Sport. Type II chemotherapy-related cardiac dysfunction: Predicting difficult intubation in apparently normal patients: Cardiotooxicidad Natl Cancer Inst.
Singal PK, Iliskovic N. Cardiotoxicity induced by chemotherapy and antibody therapy. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Physical activity and survival after colorectal cancer diagnosis. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. There are few studies that are concerned with the toxicity of monoclonal antibodies in the treatment of malignancies.
J Heart Lung Transplant. Tolerability of first-line therapy for metastatic renal cell carcinoma. Perioperative scores to cardootoxicidad mortality in surgical oncologic patients: Identify the main adverse reactions presented by patients with HER2 positive breast cancer from an outpatient clinic specialized in chemotherapy in the city of Caruaru-PE, after the use of Trastuzumab. Bleomycin induced pulmonary toxicity: Robson D, Verma S. Reversible cardiotoxicity with tyrosine kinase inhibitors.
Muerte súbita debida a cardiotoxicidad aguda inducida por antraciclinas
Cardiac surgery in patients with previous carcinoma of the breast and mediastinal irradiation: Docetaxel does not impair cardiac autonomic function in breast cancer patients previously treated with anthracyclines.
Risk factors for atrial fibrillation after lung cancer surgery: Statin use is associated with improved prostate cancer survival: Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. What is QT interval prolongation? Singhal S, Mehta J.